{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:21:47Z","timestamp":1759990907641,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493968671"},{"type":"electronic","value":"9781493968695"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6869-5_13","type":"book-chapter","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T13:58:42Z","timestamp":1491227922000},"page":"225-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Alphavirus-Based Vaccines"],"prefix":"10.1007","author":[{"given":"Kenneth","family":"Lundstrom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"13_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12250-012-3241-1","volume":"27","author":"MP Deng","year":"2012","unstructured":"Deng MP, Hu ZH, Wang HL, Deng F (2012) Developments of subunit and VLP vaccines against influenza A virus. Virol Sin 27:145\u2013153","journal-title":"Virol Sin"},{"key":"13_CR2","doi-asserted-by":"publisher","first-page":"h988","DOI":"10.1136\/bmj.h988","volume":"350","author":"LH Butterfield","year":"2015","unstructured":"Butterfield LH (2015) Cancer vaccines. Br Med J 350:h988","journal-title":"Br Med J"},{"key":"13_CR3","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.3390\/v6062392","volume":"6","author":"K Lundstrom","year":"2014","unstructured":"Lundstrom K (2014) Alphavirus-based vaccines. Viruses 6:2392\u20132415","journal-title":"Viruses"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/nbt1291-1356","volume":"9","author":"P Liljestrom","year":"1991","unstructured":"Liljestrom P, Garoff H (1991) A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio\/Technology 9:1356\u20131361","journal-title":"Bio\/Technology"},{"key":"13_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1126\/science.2922607","volume":"243","author":"C Xiong","year":"1989","unstructured":"Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV (1989) Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243:1188\u20131191","journal-title":"Science"},{"key":"13_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0042-6822(89)90526-6","volume":"171","author":"NL Davies","year":"1989","unstructured":"Davies NL, Brown KW, Johnston RE (1989) In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology 171:189\u2013204","journal-title":"Virology"},{"key":"13_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/viro.2000.0635","volume":"278","author":"S Schultz-Cherry","year":"2000","unstructured":"Schultz-Cherry S, Dybing JK, Davis NL, Williamson C, Suarez DL, Johnston R, Perdue ML (2000) Influenza virus (A\/HK\/156\/97) hemagglutinin expressed by an alphavirus replicon system protects against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278:55\u201359","journal-title":"Virology"},{"key":"13_CR8","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/0264-410X(94)90074-4","volume":"12","author":"X Zhou","year":"1994","unstructured":"Zhou X, Berglund P, Rhodes G, Parker SE, Jondal M, Liljestrom P (1994) Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12:1510\u20131514","journal-title":"Vaccine"},{"key":"13_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/aid.1998.14.1369","volume":"14","author":"D Brand","year":"2000","unstructured":"Brand D, Lemiale F, Turbica I, Buzelay L, Brunet S, Barin F (2000) Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles. AIDS Res Hum Retroviruses 14:1369\u20131377","journal-title":"AIDS Res Hum Retroviruses"},{"key":"13_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0166-0934(99)00009-9","volume":"79","author":"A Giraud","year":"1999","unstructured":"Giraud A, Ataman-Onal Y, Battail N, Piga N, Brand D, Mandrand B, Verrier B (1999) Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNA. J Virol Methods 79:75\u201384","journal-title":"J Virol Methods"},{"key":"13_CR11","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","volume":"75","author":"JA Wilson","year":"2001","unstructured":"Wilson JA, Hart MK (2001) Protection from Ebola virus mediated by cytotoxic T-lymphocytes specific for the viral nucleoprotein. J Virol 75:2660\u20132664","journal-title":"J Virol"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","volume":"19","author":"P Pushko","year":"2000","unstructured":"Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19:142\u2013153","journal-title":"Vaccine"},{"key":"13_CR13","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1128\/JVI.03361-12","volume":"87","author":"AS Herbert","year":"2013","unstructured":"Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE, Stonier SW, Muhammad MA, Bakken RR, Prugar LI, Olinger GG, Groebner JL, Lee JS, Pratt WD, Custer M, Kamrud KI, Smith JF, Hart MK, Dye JM (2013) Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with Ebolavirus. J Virol 87:4952\u20134964","journal-title":"J Virol"},{"key":"13_CR14","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/v7052321","volume":"7","author":"K Lundstrom","year":"2015","unstructured":"Lundstrom K (2015) Alphaviruses in gene therapy. Viruses 7:2321\u20132333","journal-title":"Viruses"},{"key":"13_CR15","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1016\/j.vaccine.2007.06.058","volume":"25","author":"TP Moran","year":"2007","unstructured":"Moran TP, Burgents JE, Long B, Ferrer I, Jaffee EM, Tisch RM, Johnston R, Serody JS (2007) Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine 25:6604\u20136612","journal-title":"Vaccine"},{"key":"13_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/sj.cgt.7700300","volume":"8","author":"LB Lachman","year":"2001","unstructured":"Lachman LB, Rao XM, Kremer RH, Ozpolat B, Kiriakova G, Price JE (2001) DNA vaccination against neu reduces breast cancer incidence and metastasis in mice. Cancer Gene Ther 8:259\u2013268","journal-title":"Cancer Gene Ther"},{"key":"13_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/10548","volume":"5","author":"H Ying","year":"1999","unstructured":"Ying H, Zaks TZ, Wang RF, Irvine KR, Kammula US, Marincola FM, Leitner WW, Restifo NP (1999) Cancer therapy using a self-replicating RNA vaccine. Nat Med 5:823\u2013827","journal-title":"Nat Med"},{"key":"13_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/01459740.2012.679981","volume":"32","author":"KA Jansen","year":"2013","unstructured":"Jansen KA (2013) The 2005\u20132007 Chikungunya epidemic in Reunion: ambiguous etiologies, memories, and meaning-making. Med Anthropol 32:174\u2013189","journal-title":"Med Anthropol"},{"key":"13_CR19","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","volume":"18","author":"MK Hart","year":"2000","unstructured":"Hart MK, Caswell-Stephan K, Bakken R, Tammariello R, Pratt W, Davis N, Johnston RE, Smith J, Steele K (2000) Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18:3067\u20133075","journal-title":"Vaccine"},{"key":"13_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000928","volume":"5","author":"K Mallilankaraman","year":"2011","unstructured":"Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, Ferraro B, Stabenow J, Vijayachari P, Sundaram SG, Muruganandam N, Sarangan G, Srikanth P, Khan AS, Lewis MG, Kim JJ, Sardesai NY, Muthumani K, Weiner DB (2011) A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates. PLoS Negl Trop Dis 5:e928","journal-title":"PLoS Negl Trop Dis"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2000.62.681","volume":"62","author":"R Edelman","year":"2000","unstructured":"Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA (2000) Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 62:681\u2013685","journal-title":"Am J Trop Med Hyg"},{"key":"13_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","volume":"28","author":"DI Bernstein","year":"2009","unstructured":"Bernstein DI, Reap EA, Katen K, Watson A, Smith K, Norberg P, Olmsted RA, Hoeper A, Morris J, Negri S, Maughan MF, Chulay JD (2009) Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28:484\u2013493","journal-title":"Vaccine"},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaccine.2012.11.096","volume":"31","author":"SF Slovin","year":"2013","unstructured":"Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP, Israel R, Sher HI, Morris S (2013) A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine 31:943\u2013949","journal-title":"Vaccine"},{"key":"13_CR24","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0028-3908(99)00265-8","volume":"39","author":"C Schweitzer","year":"2000","unstructured":"Schweitzer C, Kratzeisen C, Adam G, Lundstrom K, Malherbe P, Ohresser S, Stadler H, Wichmann J, Woltering T, Mutel V (2000) Characterization of [3H] LY-354740 binding of rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors. Neuropharmacology 39:1700\u20131706","journal-title":"Neuropharmacology"},{"key":"13_CR25","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nbt0893-916","volume":"11","author":"P Berglund","year":"1993","unstructured":"Berglund P, Sj\u00f6berg M, Garoff H, Atkins GJ, Sheahan BJ, Liljestrom P (1993) Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio\/Technology 11:916\u2013920","journal-title":"Bio\/Technology"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/JVI.65.8.4107-4113.1991","volume":"65","author":"P Lijestrom","year":"1991","unstructured":"Lijestrom P, Lusa S, Huylebroeck D, Garoff H (1991) In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular weight membrane protein modulates virus release. J Virol 65:4107\u20134113","journal-title":"J Virol"},{"key":"13_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13550280390173382","volume":"9","author":"MJ V\u00e4h\u00e4-Koskela","year":"2003","unstructured":"V\u00e4h\u00e4-Koskela MJ, Tuittila MT, Nygardas PT, Nyman JK, Ehrengruber MU, Renggli M, Hinkkanen AE (2003) A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus. J Neurovirol 9:1\u201315","journal-title":"J Neurovirol"},{"key":"13_CR28","doi-asserted-by":"publisher","first-page":"18060","DOI":"10.1074\/jbc.273.29.18060","volume":"273","author":"DP DiCiommo","year":"1998","unstructured":"DiCiommo DP, Bremner R (1998) Rapid, high-level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 273:18060\u201318066","journal-title":"J Biol Chem"},{"key":"13_CR29","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1167\/iovs.04-0140","volume":"45","author":"DP DiCiommo","year":"2004","unstructured":"DiCiommo DP, Duckett A, Burcescu I, Bremner R, Gallie BR (2004) Retinoblastoma protein purification and transduction of retina and retinoblastoma cells using improved alphavirus vectors. Invest Ophthalmol Vis Sci 45:3320\u20133329","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"13_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jviromet.2007.10.007","volume":"148","author":"L Ulper","year":"2008","unstructured":"Ulper L, Sarand I, Rausalu K, Merits A (2008) Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with a n inserted intron. J Virol Methods 148:265\u2013270","journal-title":"J Virol Methods"},{"key":"13_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jviromet.2013.07.058","volume":"193","author":"AL Puglia","year":"2013","unstructured":"Puglia AL, Rezende AG, Jorge SA, Wagner R, Pereira CA, Astray RM (2013) Quantitative RT-PCR for titration of replication-defective recombinant Semliki Forest virus. J Virol Methods 193:647\u2013652","journal-title":"J Virol Methods"},{"key":"13_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jviromet.2012.09.026","volume":"187","author":"D Juare","year":"2013","unstructured":"Juare D, Long KC, Aguilar P, Kochel TJ, Halsey JS (2013) Assessment of plaque assay methods for alphaviruses. J Virol Methods 187:185\u2013189","journal-title":"J Virol Methods"},{"key":"13_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012670","volume":"5","author":"F Avogadri","year":"2010","unstructured":"Avogadri F, Merghoub T, Maughan MF, Hirschhorn-Cymerman D, Morris J, Ritter E, Olmsted R, Houghton AN, Wolchok DJ (2010) Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity. PLoS One 5:e12670","journal-title":"PLoS One"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nm813","volume":"5","author":"WW Leitner","year":"2003","unstructured":"Leitner WW, Hwang NL, de Veer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP (2003) Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 5:33\u201339","journal-title":"Nat Med"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.1998.9357","volume":"250","author":"G Colombage","year":"1998","unstructured":"Colombage G, Hall R, Pavy M, Lobigs M (1998) DNA-based and alphavirus-vectored immunization with PrM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250:151\u2013163","journal-title":"Virology"},{"key":"13_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1525-0016(02)00056-4","volume":"7","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom K, Abenavoli A, Malgaroli A, Ehrengruber MU (2003) Novel Semliki Forest virus vectors with reduced toxicity and temperature-sensitivity for long-term enhancement of transgene expression. Mol Ther 7:202\u2013209","journal-title":"Mol Ther"},{"key":"13_CR37","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1073\/pnas.95.22.12989","volume":"95","author":"EV Agapov","year":"1998","unstructured":"Agapov EV, Frolov I, Lindenbach BD, Pragal PM, Schlesinger S, Rice CM (1998) Noncythopathic Sindbis virus RNA vectors for heterologous gene expression. Proc Natl Acad Sci U S A 95:12989\u201312994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nbt1194-1127","volume":"12","author":"EM Sj\u00f6berg","year":"1994","unstructured":"Sj\u00f6berg EM, Suomalainen M, Garoff H (1994) A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Bio\/Technology 12:1127\u20131131","journal-title":"Bio\/Technology"},{"key":"13_CR39","doi-asserted-by":"crossref","unstructured":"Voytas, D, and Ke, N, (2001) Detection and quantitation of radiolabeled proteins and DNA in gels and blot. Curr Protoc Mol Biol, Appendix 3, 3A","DOI":"10.1002\/0471142727.mba03as48"}],"container-title":["Methods in Molecular Biology","Recombinant Virus Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6869-5_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T21:49:12Z","timestamp":1601848152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6869-5_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493968671","9781493968695"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6869-5_13","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"4 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}